American Cannabis Company, Inc. Executes Definitive Agreement to Acquire Naturaleaf™ in Southern Colorado
DENVER, CO, March 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC” or “Company”)...
News
Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology,...
Brain Scientific Announces Collaboration with JelikaLite in New Clinical Trial
The two neurology device companies will join forces in a clinical trial seeking to reduce the symptoms of autism in...
BrightInsight and AstraZeneca Collaborate to Enhance Disease Management
BrightInsight Accelerates Time to Market for the AstraZeneca AMAZE Disease Management Platform Within a Regulatory-Compliant Environment BrightInsight and AstraZeneca Collaborate...
Better Choice Announces Formation of Strategic Advisory Committee to Review Potential Strategic Opportunities
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice” or the “Company”), an animal...
Skye Bioscience’s Cannabinoid-Derived Drug Candidate, THCVHS, Demonstrates No Eye Irritation in Preclinical Assessment
San Diego, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical...
Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 ALIGN Study of Atrasentan for Patients with IgA Nephropathy
Phase 2 AFFINITY Trial of Atrasentan for Patients with Glomerular Diseases Also on Track to Begin Enrollment in the First...
Adagene Announces First Patients Dosed in Global Phase 1 Clinical Trial of ADG126, Lead SAFEbody™ Program
SAFEbody technology enables precision masking of antibodies for enhanced safetySAN FRANCISCO and SUZHOU, China, March 16, 2021 (GLOBE NEWSWIRE) --...
IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS
VANCOUVER, B.C. / BOSTON, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF)...
Vaccinex Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update
Reported top-line results from Phase 2 SIGNAL study that indicates potential cognitive benefit of pepinemab in neurodegenerative disease. New Alzheimer’s...
Biotricity CEO Discusses Calculated Growth Strategy in Audio Interview with SmallCapVoice.com
AUSTIN, Texas, March 16, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Dr....
SmileDirectClub Announces Expansion of Oral Care Products to Walmart Canada Locations
The Leader in Telehealth Broadens Oral Care Retail Presence with Walmart Partnership SmileDirectClub Electric Toothbrush SmileDirectClub's innovative oral care products...
Colorado State University, Flint Animal Cancer Center Applies Sensus Healthcare’s SRT Non-Surgical Treatment to Animal Care
Effectiveness and Utility of SRT-100™ Demonstrated in the Companion-Animal Market Best-in-class localization features of SRT-100 enable new radiation therapy options...
Immutep Enters Second Collaboration With MSD For A New Randomised Phase IIB Trial In Head And Neck Cancer
New Phase IIb trial called TACTI-003, to evaluate eftilagimod alpha in combination with MSD’s KEYTRUDA® (pembrolizumab) in 1st line head...
Protech Continues Rapid Expansion with Opening of Two New Locations Focused on Respiratory Therapy Products and Services
Accelerating Scale by Expanding Geographical Operating Footprint with New Location in Florida and New HampshireCINCINNATI, March 16, 2021 (GLOBE NEWSWIRE)...
Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments...
Nabriva Publishes Clinical Data Analysis Highlighting Benefits of Outpatient Management of Community Acquired Bacterial Pneumonia (CABP) with Oral XENLETA® (lefamulin)
-Post Hoc analysis published in The Journal of Emergency Medicine demonstrates patients with moderate to severe CABP can be managed...
Amolyt Pharma to Present Preliminary Phase 1 Data on AZP-3601 for Hypoparathyroidism and Additional Preclinical Data on AZP-3404 at ENDO 2021
Four abstracts accepted as poster presentations for the Endocrine Society’s Annual MeetingLYON, France and NEWTON, Mass., March 16, 2021 (GLOBE...
Histogen and Amerimmune Announce First Patient Dosed in Phase 1 Study of Emricasan in Symptomatic COVID-19 Patients
Topline Results Expected in the Second Quarter of 2021SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO)...
Pliant Therapeutics Announces Successful Completion of PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company...